Mineralys Therapeutics In...
(MLYS)
undefined
undefined%
At close: undefined
11.90
0.59%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -71.90M | -29.80M | -19.41M | -3.43M |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | 5.06M | 455.00K | 80.00K | 1K |
Other Working Capital | -7.47M | 772.00K | 4.08M | 480.00K |
Other Non-Cash Items | -6.87M | -649.00K | 684.00K | 482.00K |
Deferred Income Tax | - | - | - | - |
Change in Working Capital | -7.47M | 772.00K | 4.08M | 480.00K |
Operating Cash Flow | -81.17M | -29.22M | -14.56M | -2.46M |
Capital Expenditures | - | - | - | - |
Acquisitions | - | - | - | - |
Purchase of Investments | -347.97M | -71.76M | - | - |
Sales Maturities Of Investments | 187.50M | 50.00M | - | - |
Other Investing Acitivies | - | -21.76K | - | - |
Investing Cash Flow | -160.47M | -21.76M | - | - |
Debt Repayment | - | - | - | - |
Common Stock Repurchased | - | -1.63M | - | -20.00K |
Dividend Paid | - | - | - | - |
Other Financial Acitivies | 516.00K | 129.65M | 23.81M | 3.83M |
Financial Cash Flow | 203.25M | 128.02M | 23.81M | 3.83M |
Net Cash Flow | -38.40M | 77.04M | 9.25M | 1.37M |
Free Cash Flow | -81.17M | -29.22M | -14.56M | -2.46M |